Drew describes how digestion is connected to immunity
Pipeline Innovation: Beyond Weight Loss The obesity pipeline remains robust, and IQVIA estimated there are over 193 assets in development as of October 2025, an increase from 181 assets in development in May 2025
Obesity is a chronic, relapsing disease, says Dr
This study found that participants regained a significant portion of lost weight after discontinuing semaglutide: Rubino D et al., Discontinuation of GLP-1 Receptor Agonist Therapy and Weight Regain, Frontiers in Endocrinology , 2021
Deficiencies can be caused by genetic disorders, malnutrition, malabsorption and kidney dialysis, and affect the heart, skeletal muscles, liver, nerve, and endocrine functions
Endotoxin and sterility testing (for injectable-intended products): Many research vendor COAs do not include these